This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Tincture contains 15 mg dose of CBN and THC per milliliter.
June 21, 2021
Parallel’s retail brand goodblend has introduced a new product featuring cannabinol (CBN) for patients registered in the Texas Compassionate Use Program.
Company set to open two more dispensaries in Illinois in April.
April 5, 2021
Subject to regulatory approval as discussed below, Parallel is expected to own six Illinois dispensary locations, which will expand Parallel's active operations to six high-growth, limited license states.
Kunicki will lead the company’s finance and operations functions.
March 1, 2021
Kunicki will lead Parallel's finance and operations functions, as well as oversee corporate finance, shared services activities and operational management of the organization.